Alethea Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,330
Closed -$347K 12
2024
Q4
$347K Buy
+1,330
New +$395K 0.3% 21
2024
Q3
Sell
-1,784
Closed -$557K 32
2024
Q2
$557K Buy
1,784
+193
+12% +$56.7K 0.42% 8
2024
Q1
$452K Buy
+1,591
New +$466K 0.37% 26
2023
Q2
Sell
-1,175
Closed -$284K 54
2023
Q1
$284K Hold
1,175
0.3% 51
2022
Q4
$309K Hold
1,175
0.3% 25
2022
Q3
$265K Sell
1,175
-375
-24% -$90.9K 0.33% 43
2022
Q2
$377K Sell
1,550
-200
-11% -$49K 0.47% 27
2022
Q1
$423K Sell
1,750
-650
-27% -$149K 0.38% 44
2021
Q4
$540K Hold
2,400
0.46% 25
2021
Q3
$510K Hold
2,400
0.45% 41
2021
Q2
$585K Hold
2,400
0.37% 39
2021
Q1
$597K Hold
2,400
0.36% 46
2020
Q4
$552K Sell
2,400
-2,452
-51% -$565K 0.28% 40
2020
Q3
$1.23M Buy
4,852
+2,452
+102% +$607K 0.83% 14
2020
Q2
$566K Hold
2,400
0.33% 34
2020
Q1
$487K Sell
2,400
-3,191
-57% -$697K 0.32% 31
2019
Q4
$1.35M Buy
5,591
+2,991
+115% +$659K 0.58% 6
2019
Q3
$503K Hold
2,600
0.32% 40
2019
Q2
$479K Hold
2,600
0.31% 46
2019
Q1
$494K Sell
2,600
-1,664
-39% -$318K 0.35% 41
2018
Q4
$830K Buy
4,264
+1,664
+64% +$325K 1.21% 18
2018
Q3
$539K Hold
2,600
0.81% 39
2018
Q2
$480K Hold
2,600
0.82% 37
2018
Q1
$443K Buy
2,600
+520
+25% +$95.5K 0.6% 51
2017
Q4
$362K Buy
+2,080
New +$368K 0.58% 58
2017
Q3
Sell
-1,551
Closed -$267K 78
2017
Q2
$267K Buy
+1,551
New +$252K 0.3% 66

Other funds holding AMGN

Alethea Capital Management's AMGN Position: Q1 2025 in Review

Alethea Capital Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,330 shares — an estimated $347K sold.

Alethea Capital Management first reported a position in AMGN in Q2 2017 and held it in 26 quarters. The position peaked at $1.35M in Q4 2019. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Alethea Capital Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Alethea Capital Management sold 1,330 Amgen shares in Q1 2025, an estimated $347K.
  • Alethea Capital Management first reported a position in Amgen in Q2 2017 and held it in 26 quarters.
  • Alethea Capital Management's Amgen position peaked at $1.35M in Q4 2019.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Alethea Capital Management's 13F filing for Q1 2025, filed 14 May 2025.